Literature DB >> 10483991

Esophageal and gastric nitric oxide synthesizing innervation in primary achalasia.

R De Giorgio1, M P Di Simone, V Stanghellini, G Barbara, M Tonini, B Salvioli, S Mattioli, R Corinaldesi.   

Abstract

OBJECTIVE: We performed a qualitative and quantitative analysis of the nitrinergic neurons in the esophageal and gastric component of the lower esophageal sphincter (LES) and gastric fundus of patients with primary achalasia.
METHODS: Four muscle strips were obtained from the esophagogastric junction (two from the esophageal and two from the gastric side of the LES), and two from the gastric fundus of six patients with endstage achalasia who underwent an esophagogastric myotomy plus hemifundoplication. Control specimens were obtained from eight patients who underwent surgery for cancer of the thoracic esophagus. Fixed sections were processed for NADPH-diaphorase histochemistry and the number (mean +/- SE) of nitrinergic neurons per section was visually quantified in each specimen.
RESULTS: In the controls, nitric oxide fibers were distributed to the muscle layer and surrounding myenteric neurons of both the LES and the gastric fundus. By contrast, achalasic patients showed a marked decrease of nitric oxide nerves and labeled neurons in both esophageal and gastric components of the LES and the gastric fundus. Quantitative assessment in achalasic patients showed that the mean number of nitrinergic neurons was dramatically reduced in both the esophageal (0.2 +/- 0.1) and the gastric component (2 +/- 0.6) of the LES as compared to those in controls (15 +/- 5 and 12 +/- 4, respectively; p < 0.05); nitrinergic neurons in the gastric fundus (3 +/- 1) were significantly reduced in comparison to those of controls (10 +/- 2) (p < 0.05).
CONCLUSIONS: Our results indicate that achalasia is a motor disorder with an intrinsic inhibitory denervation of the esophageal and gastric component of the LES and of the proximal stomach, thus providing further evidence for an extraesophageal extension of the disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10483991     DOI: 10.1111/j.1572-0241.1999.01357.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  28 in total

Review 1.  Tissue engineering in the gut: developments in neuromusculature.

Authors:  Khalil N Bitar; Shreya Raghavan; Elie Zakhem
Journal:  Gastroenterology       Date:  2014-03-27       Impact factor: 22.682

Review 2.  Hydrogen sulphide as a signalling molecule regulating physiopathological processes in gastrointestinal motility.

Authors:  M Jimenez; V Gil; M Martinez-Cutillas; N Mañé; D Gallego
Journal:  Br J Pharmacol       Date:  2017-07-27       Impact factor: 8.739

3.  The appendix as a viable source of neural progenitor cells to functionally innervate bioengineered gastrointestinal smooth muscle tissues.

Authors:  Elie Zakhem; Stephen L Rego; Shreya Raghavan; Khalil N Bitar
Journal:  Stem Cells Transl Med       Date:  2015-04-14       Impact factor: 6.940

4.  Achalasia and thyroid disease.

Authors:  Mohammad Hassan Emami; Mostafa Raisi; Jaleh Amini; Hamed Daghaghzadeh
Journal:  World J Gastroenterol       Date:  2007-01-28       Impact factor: 5.742

5.  Megaesophagus in a line of transgenic rats: a model of achalasia.

Authors:  J Pang; T M Borjeson; S Muthupalani; R M Ducore; C A Carr; Y Feng; M P Sullivan; V Cristofaro; J Luo; J M Lindstrom; J G Fox
Journal:  Vet Pathol       Date:  2014-01-23       Impact factor: 2.221

Review 6.  Stem cell therapy for GI neuromuscular disorders.

Authors:  Khalil N Bitar; Shreya Raghavan
Journal:  Curr Gastroenterol Rep       Date:  2014-12

7.  Serum from achalasia patients alters neurochemical coding in the myenteric plexus and nitric oxide mediated motor response in normal human fundus.

Authors:  S Bruley des Varannes; J Chevalier; S Pimont; J-C Le Neel; M Klotz; K-H Schafer; J-P Galmiche; M Neunlist
Journal:  Gut       Date:  2005-08-16       Impact factor: 23.059

8.  Antineuronal antibodies in idiopathic achalasia and gastro-oesophageal reflux disease.

Authors:  P L Moses; L M Ellis; M R Anees; W Ho; R I Rothstein; J B Meddings; K A Sharkey; G M Mawe
Journal:  Gut       Date:  2003-05       Impact factor: 23.059

Review 9.  Enteric autoantibodies and gut motility disorders.

Authors:  Purna Kashyap; Gianrico Farrugia
Journal:  Gastroenterol Clin North Am       Date:  2008-06       Impact factor: 3.806

Review 10.  The management of esophageal achalasia: from diagnosis to surgical treatment.

Authors:  Adrian Dobrowolsky; P Marco Fisichella
Journal:  Updates Surg       Date:  2013-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.